School of Medicine
Showing 51-100 of 132 Results
-
Joseph Levitt, MD, MS
Associate Professor of Medicine (Pulmonary and Critical Care Medicine)
Current Research and Scholarly InterestsMy research focuses on the physiolgogic and biomarker characteristics of early acute lung injury (ALI) prior to need for mechanical ventilation. While, to date no pharmacologic treatment has improved survival in ALI, following the paradigm of early goal directed therapy for severe sepsis, clinical benefit may derive from identifying patients and initiating treatment prior to the need for positive pressure ventilation (and therefore prior to meeting current study entry criteria).
-
David R. Li, MD
Affiliate, Department Funds
Fellow in Medicine - Med/Pulmonary, Allergy & Critical Care MedicineBioDr. Li is a current Critical Care Medicine fellow at Stanford Healthcare, where he stayed on after completing residency training in Emergency Medicine. He is interested in healthcare informatics and is an Epic Physician Builder. Dr. Li is active in organized medicine & health policy, currently holding leadership positions in California Medical Association, and previously serving as a California Senate legislative intern.
-
Anne Liu
Clinical Associate Professor, Pediatrics - Immunology and Allergy
Clinical Associate Professor (By courtesy), Medicine - Pulmonary, Allergy & Critical Care MedicineBioDr. Liu is a board-certified, fellowship-trained specialist in allergy/immunology and infectious disease. She is also a clinical associate professor in the Department of Medicine, Division of Infectious Diseases and the Department of Pediatrics, Division of Allergy, Immunology, and Rheumatology at Stanford University School of Medicine.
Dr. Liu treats infections in patients with compromised immune systems, whether due to a primary immune deficiency or a condition like cancer or organ transplant. She helps patients to develop tolerance to medications they are allergic to so that they can receive the best, and sometimes the only, treatments available to them. She also treats allergies to antibiotics, aspirin, NSAIDs, chemotherapy, and more. She sees patients both long term and for urgent referrals, such as in cases of perioperative anaphylaxis. Dr. Liu also helps pediatric patients manage drug and food allergies.
One of Dr. Liu’s areas of focus is helping patients with allergies to antibiotics determine when they have lost an allergy, what antibiotics they can tolerate, and when to induce tolerance to an antibiotic. This not only can benefit the patient, but also have a positive public health impact, as labeling patients with a penicillin allergy may negatively affect their care and increase use
of broad-spectrum antibiotics.
She collaborates closely with colleagues from other disciplines, including pulmonology, otolaryngology, oncology, cardiology, dermatology, anesthesiology, and surgery. Her key objective in working with referring physicians is to help them safely deliver the best care for their patients.
For patients and families, Dr. Liu strives to help them navigate their care journey with as much ease and dignity as possible during what may be the most challenging time of their life. Her goal is to offer patients options, even when it may appear that they have no options left.
Dr. Liu’s research interests include optimizing care of patients with antibiotic allergies, including through use of decision support tools.
Dr. Liu has authored articles in the New England Journal of Medicine, Journal of Immunology, Journal of Allergy and Clinical Immunology in Practice, Clinical and Experimental Allergy, Mucosal Immunology, Diagnostic Microbiology and Infectious Disease, Science, and other publications. Dr. Liu authored the book chapter “Hypersensitivity Reactions to Monoclonal Antibodies” in Drug Allergy Testing.
Dr. Liu is certified in infectious disease by the American Board of Internal Medicine and in allergy and immunology by the American Board of Allergy and Immunology. She is also a member of the American College of Physicians, Infectious Diseases Society of America, and American Academy of Allergy, Asthma, and Immunology.
She has given presentations on antibiotic allergies, drug desensitization, and aspirin-exacerbated respiratory disease, among other topics. Dr. Liu’s honors include recognition from the American Academy of Asthma, Allergy, and Immunology, the American Medical Women’s Association, and the National Institutes of Health. -
Meghan Marmor
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioDr. Marmor is board certified in pulmonary and critical care medicine. She specializes in the treatment of individuals with chronic airway diseases, bronchiectasis, and chronic lung infections.
-
Carlos Milla
Professor of Pediatrics (Pulmonary Medicine) and, by courtesy, of Medicine (Pulmonary and Critical Care Medicine)
Current Research and Scholarly InterestsAt Stanford University I developed and currently direct the CF Translational Research Center. The overarching goal of the center is to provide the groundwork to streamline, accelerate, and promote the translation of basic discoveries into effective therapies and interventions to benefit patients affected by cystic fibrosis. My laboratory group currently has three main lines of investigation: respiratory cell biology in CF; remote biochemical monitoring; and lung physiology in young children.
-
Joshua Mooney
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
Current Research and Scholarly InterestsOutcomes and Health Services Research in Advanced Lung Disease & Lung Transplant
-
Margaret Jane Neff
Clinical Associate Professor (Affiliated), Medicine - Med/Pulmonary, Allergy & Critical Care Medicine
Medical Director--Vapahcs Medical Surgical Icu, Medicine - Med/Pulmonary, Allergy & Critical Care MedicineBioMy training is in Pulmonary & Critical Care Medicine, and I've been blessed to be part of the care of many patients and their families. My clinical research interests have been in the field of critical care medicine and ARDS, a type of acute respiratory failure seen commonly in patients with severe injuries or illnesses. I also have a particular interest in evaluating and improving processes for care. Issues like standardizing processes to improve reliability, improving safety of handoffs, and exploring ways to teach "roundsmanship" (the process of discussing patients' care with a group of providers) are current interests of mine.
The future of medical care depends on training the next generation of providers, and I'm thankful to be part of training this next generation. Teaching at the bedside or in formal classroom settings gives me great joy and satisfaction. I'm delighted to work with a great, multidisciplinary team of physicians, nurse practitioners, nurses, respiratory therapists, and pharmacists. I add to that team our patients and families, for it truly takes a team to provide care that is both excellent and compassionate. -
Mark Nicolls
Stanford University Professor of Pulmonary and Critical Care Medicine
Current Research and Scholarly InterestsOur lab focuses primarily on the contribution of the immune response to lung disease. We are specifically examining the contribution of inflammation to the development of vascular injury in transplantation, pulmonary hypertension and lymphedema.
-
Robert N. Proctor
Professor of History and, by courtesy, of Medicine (Pulmonary and Critical Care Medicine)
Current Research and Scholarly InterestsTobacco and cigarette design; human origins and evolution; changing concepts of health and disease; medical history and medical politics
-
Rishi Raj
Clinical Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioDr. Rishi Raj is a Clinical Professor of Medicine at Stanford University, where he directs the Interstitial Lung Disease program. He has practiced pulmonary and critical care medicine for over two decades and specializes in the diagnosis and treatment of interstitial lung diseases.
His primary clinical interest encompasses a range of interstitial lung diseases, including idiopathic pulmonary fibrosis, other idiopathic interstitial lung diseases, drug-induced interstitial lung diseases, interstitial lung disease associated with connective tissue diseases such as scleroderma, rheumatoid arthritis, dermatomyositis, sarcoidosis, hypersensitivity pneumonitis, and other various interstitial lung diseases. His other clinical interest is acute respiratory failure associated with interstitial lung diseases, and Dr. Raj attends regularly in the medical intensive care units.
Dr. Raj's clinical research explores the use of radiologic biomarkers to predict outcomes in various interstitial lung diseases. He is a principal investigator and co-investigator in numerous clinical trials, examining new therapies for treating idiopathic pulmonary fibrosis and other interstitial lung diseases. -
Meghan Ramsey
Clinical Associate Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioDr. Meghan Ramsey is a Clinical Associate Professor in the Division of Pulmonary, Allergy, and Critical Care Medicine. She received her undergraduate degree from Lafayette College in Pennsylvania with a major in Neuroscience. She then attended Stanford University for medical school where she stayed to complete her internal medicine residency, and pulmonary/critical care fellowship. Her clinical time is split between the inpatient setting in the medical ICU and the ambulatory setting in Interventional Pulmonology with a focus on thoracic malignancies. Outside of her clinical time she has a dedicated commitment to teaching, serving as a mentor for residents and fellows, as well as leading as a co-director the pulmonary physiology course for medical students.
-
Norman Rizk
Berthold and Belle N. Guggenhime Professor, Emeritus
Current Research and Scholarly InterestsI am interested in the prevention and control of critical care-related illnesses and complications, including ventilator-associated pneumonia, spread of nosocomial infections, and prognosis of multiple organ system failure in intensive care units. Infections and complications of therapy in immunocompromised hosts, including effects of chemotherapy and hematopoetic stem cell transplants is another interest.
-
Angela Rogers
Associate Professor of Medicine (Pulmonary and Critical Care)
Current Research and Scholarly InterestsWe use genetics and genomics methodologies to identify novel ARDS pathobiology; we hope that this will enable identification of novel biomarkers, phenotypes, and treatments for the disease. We are building a plasma biobank of critically ill patients at Stanford, with a particular focus on metabolic changes in critical illness.
-
Glenn Rosen
Associate Professor of Medicine (Pulmonary and Critical Care Medicine), Emeritus
Current Research and Scholarly InterestsOur laboratory examines apoptotic and cell signaling pathways in cancer and lung disease. We are studying signaling pathways that regulate oxidative stress responses and cancer cell growth. Part of these studies focus on analysis of non-canonical transcription regulatory functions of the TERC and Tert components of telomerase in lung disease and cancer.
-
Stephen Ruoss
Professor of Medicine (Pulmonary and Critical Care)
Current Research and Scholarly InterestsWe have an active collaborative project examining basic and clinical aspects of non-tuberculous mycobacterial lung infection in non-immune compromised adults. Studies have examined possible cellular immune mechanisms for increased susceptibility to these infections, and are also investigating aspects of optimal diagnosis and treatment. In addition, a clinical and translational research program is investigating the causes and genetic factors underlying the evolution of bronchiectasis.
-
Pablo Amador Sanchez
Contingent, Medicine - Med/Pulmonary, Allergy & Critical Care Medicine
BioDr. Pablo Sanchez is a medical fellow at Stanford University. He earned a degree in physiology at The University of Arizona and received his M.D. from The University of Arizona College of Medicine, in Tucson. He completed Internal Medicine training at Brigham & Women's Hospital/Harvard Medical School, and served as Chief Resident from 2018-2019. During residency, his research focused on clinical outcomes of the complex patient composition in the modern Cardiac Intensive Care Unit. He completed Cardiovascular Medicine fellowship at Stanford and served as Chief Fellow from 2021-2022. He is interested in cardio-pulmonary interactions in Acute Respiratory Distress Syndrome (ARDS). Under the tutelage of Dr. Angela Rogers (Pulmonary Medicine Division) and Dr. Euan Ashley (Cardiovascular Medicine Division), he plans to integrate immune-metabolic biomarker and echocardiographic profiling to identify cardiac dysfunction in ARDS. He receives funding from the National Institutes of Health through the Ruth L. Kirschstein National Research Service Award (NRSA, F32) and Loan Repayment Award. He is pursuing additional fellowship training in critical care medicine.
-
Narayan Schutz
Postdoctoral Scholar, Pulmonary and Critical Care Medicine
Postdoctoral Scholar, PsychiatryCurrent Research and Scholarly InterestsI work on using digital health technologies to detect and monitor aging relevant health indicators and outcomes using cutting-edge machine and deep learning approaches, with the goal to make our healthcare system more personalised and proactive.
Current research topics include remote gait and mobility assessments, learning health representations from large-scale smartphone data, and using novel ambient intelligence approaches to foster independent living in older adults.
